1. Home
  2. ELA vs ACHV Comparison

ELA vs ACHV Comparison

Compare ELA & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELA
  • ACHV
  • Stock Information
  • Founded
  • ELA 1965
  • ACHV N/A
  • Country
  • ELA United States
  • ACHV Canada
  • Employees
  • ELA N/A
  • ACHV N/A
  • Industry
  • ELA Consumer Specialties
  • ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • ELA Consumer Discretionary
  • ACHV Health Care
  • Exchange
  • ELA Nasdaq
  • ACHV Nasdaq
  • Market Cap
  • ELA 162.2M
  • ACHV 149.6M
  • IPO Year
  • ELA N/A
  • ACHV N/A
  • Fundamental
  • Price
  • ELA $6.47
  • ACHV $4.33
  • Analyst Decision
  • ELA Strong Buy
  • ACHV Strong Buy
  • Analyst Count
  • ELA 1
  • ACHV 5
  • Target Price
  • ELA $7.00
  • ACHV $14.80
  • AVG Volume (30 Days)
  • ELA 18.0K
  • ACHV 116.0K
  • Earning Date
  • ELA 11-05-2024
  • ACHV 11-07-2024
  • Dividend Yield
  • ELA N/A
  • ACHV N/A
  • EPS Growth
  • ELA N/A
  • ACHV N/A
  • EPS
  • ELA 0.25
  • ACHV N/A
  • Revenue
  • ELA $165,946,534.00
  • ACHV N/A
  • Revenue This Year
  • ELA N/A
  • ACHV N/A
  • Revenue Next Year
  • ELA $10.07
  • ACHV N/A
  • P/E Ratio
  • ELA $26.48
  • ACHV N/A
  • Revenue Growth
  • ELA N/A
  • ACHV N/A
  • 52 Week Low
  • ELA $4.00
  • ACHV $3.03
  • 52 Week High
  • ELA $6.50
  • ACHV $5.98
  • Technical
  • Relative Strength Index (RSI)
  • ELA 81.85
  • ACHV 40.62
  • Support Level
  • ELA $6.24
  • ACHV $4.12
  • Resistance Level
  • ELA $6.24
  • ACHV $4.46
  • Average True Range (ATR)
  • ELA 0.26
  • ACHV 0.24
  • MACD
  • ELA 0.07
  • ACHV -0.05
  • Stochastic Oscillator
  • ELA 97.46
  • ACHV 17.65

About ELA Envela Corporation

Envela Corp and its subsidiaries engage in diverse business activities within the recommerce sector. These include re-commercializing luxury hard assets, consumer electronics and IT equipment; and end-of-life recycling solutions. It operates through two segments, Consumer, and Commercial Services. The Consumer segment which generates key revenue for the company predominantly buys to resell or recycle luxury hard assets like jewelry, diamonds, gemstones, fine watches, rare coins and related collectibles, precious-metal bullion products, gold, silver, and other precious metals. The Commercial Services segment provides asset-disposition solutions to government agencies, middle-market firms, corporations, and other organizations.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

Share on Social Networks: